Learn More
Medchemexpress LLC 3-{[(3,4-dichlorophenyl)amino]carbonyl}bicyclo[2.2.1]hept-5-ene-2-carboxylic acid | 199735-88-1 | MFCD00167693 | >98.0% | 326.17 g·mol⁻¹ | C15H13Cl2NO3 | 50 MG

Supplier: Medchemexpress LLC HY10799950MG
CADD522 is a small-molecule inhibitor of RUNX2-DNA binding used in research to downregulate RUNX2-mediated transcription. It has demonstrated antiproliferative and antimetastatic effects in cell-based and animal cancer studies and is supplied as a solid for laboratory use.
- Inhibits RUNX2-DNA binding with reported IC50 ≈ 10 nM.
- Demonstrated activity in in vitro and in vivo cancer models.
- High purity appropriate for biochemical and cell-based assays.
- Provided in small research quantities for screening and mechanistic studies.
- Stable solid form; store at -20 °C under recommended conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.